CBRE GROUP INC - A (CBRE)

US12504L1098 - Common Stock

129.16  +3.51 (+2.79%)

After market: 128.85 -0.31 (-0.24%)

Fundamental Rating

5

CBRE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. CBRE has only an average score on both its financial health and profitability. CBRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes CBRE very considerable for growth investing!



6

1. Profitability

1.1 Basic Checks

In the past year CBRE was profitable.
In the past year CBRE had a positive cash flow from operations.
CBRE had positive earnings in each of the past 5 years.
CBRE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 3.86%, CBRE belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.02%, CBRE belongs to the top of the industry, outperforming 89.06% of the companies in the same industry.
With an excellent Return On Invested Capital value of 6.88%, CBRE belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
CBRE had an Average Return On Invested Capital over the past 3 years of 7.76%. This is above the industry average of 4.82%.
Industry RankSector Rank
ROA 3.86%
ROE 11.02%
ROIC 6.88%
ROA(3y)6.52%
ROA(5y)6.33%
ROE(3y)17.13%
ROE(5y)16.52%
ROIC(3y)7.76%
ROIC(5y)8.08%

1.3 Margins

Looking at the Profit Margin, with a value of 2.79%, CBRE is in the better half of the industry, outperforming 73.44% of the companies in the same industry.
In the last couple of years the Profit Margin of CBRE has declined.
CBRE has a Operating Margin of 4.23%. This is in the better half of the industry: CBRE outperforms 68.75% of its industry peers.
CBRE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 19.61%, CBRE is in line with its industry, outperforming 40.63% of the companies in the same industry.
In the last couple of years the Gross Margin of CBRE has declined.
Industry RankSector Rank
OM 4.23%
PM (TTM) 2.79%
GM 19.61%
OM growth 3Y-6.92%
OM growth 5Y-7.46%
PM growth 3Y-0.75%
PM growth 5Y-9.13%
GM growth 3Y-0.84%
GM growth 5Y-2.89%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBRE is destroying value.
Compared to 1 year ago, CBRE has less shares outstanding
The number of shares outstanding for CBRE has been reduced compared to 5 years ago.
Compared to 1 year ago, CBRE has a worse debt to assets ratio.

2.2 Solvency

CBRE has an Altman-Z score of 3.64. This indicates that CBRE is financially healthy and has little risk of bankruptcy at the moment.
CBRE's Altman-Z score of 3.64 is fine compared to the rest of the industry. CBRE outperforms 79.69% of its industry peers.
The Debt to FCF ratio of CBRE is 6.08, which is on the high side as it means it would take CBRE, 6.08 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 6.08, CBRE belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
CBRE has a Debt/Equity ratio of 0.63. This is a neutral value indicating CBRE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, CBRE perfoms like the industry average, outperforming 45.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 6.08
Altman-Z 3.64
ROIC/WACC0.77
WACC8.95%

2.3 Liquidity

A Current Ratio of 1.13 indicates that CBRE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, CBRE is doing worse than 60.94% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that CBRE should not have too much problems paying its short term obligations.
The Quick ratio of CBRE (1.13) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.03% over the past year.
The Earnings Per Share has been growing slightly by 3.20% on average over the past years.
Looking at the last year, CBRE shows a quite strong growth in Revenue. The Revenue has grown by 10.00% in the last year.
Measured over the past years, CBRE shows a quite strong growth in Revenue. The Revenue has been growing by 8.41% on average per year.
EPS 1Y (TTM)10.03%
EPS 3Y5.39%
EPS 5Y3.2%
EPS Q2Q%66.67%
Revenue 1Y (TTM)10%
Revenue growth 3Y10.27%
Revenue growth 5Y8.41%
Sales Q2Q%14.84%

3.2 Future

CBRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.71% yearly.
Based on estimates for the next years, CBRE will show a quite strong growth in Revenue. The Revenue will grow by 8.98% on average per year.
EPS Next Y32.91%
EPS Next 2Y27.03%
EPS Next 3Y23.62%
EPS Next 5Y20.71%
Revenue Next Year12.88%
Revenue Next 2Y11.94%
Revenue Next 3Y10.58%
Revenue Next 5Y8.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

5

4. Valuation

4.1 Price/Earnings Ratio

CBRE is valuated quite expensively with a Price/Earnings ratio of 30.97.
Compared to the rest of the industry, the Price/Earnings ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 75.00% of the companies listed in the same industry.
CBRE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 20.84, the valuation of CBRE can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 79.69% of the companies listed in the same industry.
CBRE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 30.97
Fwd PE 20.84

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBRE indicates a somewhat cheap valuation: CBRE is cheaper than 75.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CBRE is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 43.26
EV/EBITDA 19.93

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CBRE has a very decent profitability rating, which may justify a higher PE ratio.
CBRE's earnings are expected to grow with 23.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.94
PEG (5Y)9.67
EPS Next 2Y27.03%
EPS Next 3Y23.62%

0

5. Dividend

5.1 Amount

No dividends for CBRE!.
Industry RankSector Rank
Dividend Yield N/A

CBRE GROUP INC - A

NYSE:CBRE (12/20/2024, 8:04:00 PM)

After market: 128.85 -0.31 (-0.24%)

129.16

+3.51 (+2.79%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners98.95%
Inst Owner Change-1.14%
Ins Owners0.57%
Ins Owner Change-1.49%
Market Cap39.53B
Analysts78.82
Price Target143.57 (11.16%)
Short Float %1.58%
Short Ratio2.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.98%
Min EPS beat(2)5.07%
Max EPS beat(2)10.89%
EPS beat(4)4
Avg EPS beat(4)10.58%
Min EPS beat(4)5.07%
Max EPS beat(4)14.45%
EPS beat(8)8
Avg EPS beat(8)8.56%
EPS beat(12)10
Avg EPS beat(12)9.22%
EPS beat(16)14
Avg EPS beat(16)17.21%
Revenue beat(2)1
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-1.04%
Max Revenue beat(2)0.71%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-2.06%
Max Revenue beat(4)3.9%
Revenue beat(8)6
Avg Revenue beat(8)1.55%
Revenue beat(12)7
Avg Revenue beat(12)0.32%
Revenue beat(16)11
Avg Revenue beat(16)0.97%
PT rev (1m)13.62%
PT rev (3m)19.91%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)13.25%
EPS NY rev (1m)0.81%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)0.73%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)0.24%
Valuation
Industry RankSector Rank
PE 30.97
Fwd PE 20.84
P/S 1.15
P/FCF 43.26
P/OCF 32.36
P/B 4.55
P/tB 72.93
EV/EBITDA 19.93
EPS(TTM)4.17
EY3.23%
EPS(NY)6.2
Fwd EY4.8%
FCF(TTM)2.99
FCFY2.31%
OCF(TTM)3.99
OCFY3.09%
SpS112.12
BVpS28.4
TBVpS1.77
PEG (NY)0.94
PEG (5Y)9.67
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 11.02%
ROCE 9.41%
ROIC 6.88%
ROICexc 7.31%
ROICexgc 14.45%
OM 4.23%
PM (TTM) 2.79%
GM 19.61%
FCFM 2.66%
ROA(3y)6.52%
ROA(5y)6.33%
ROE(3y)17.13%
ROE(5y)16.52%
ROIC(3y)7.76%
ROIC(5y)8.08%
ROICexc(3y)8.83%
ROICexc(5y)9.17%
ROICexgc(3y)21.16%
ROICexgc(5y)20.69%
ROCE(3y)9.96%
ROCE(5y)10.55%
ROICexcg growth 3Y-4.79%
ROICexcg growth 5Y-13.45%
ROICexc growth 3Y-6.45%
ROICexc growth 5Y-9.49%
OM growth 3Y-6.92%
OM growth 5Y-7.46%
PM growth 3Y-0.75%
PM growth 5Y-9.13%
GM growth 3Y-0.84%
GM growth 5Y-2.89%
F-Score6
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 6.08
Debt/EBITDA 2.6
Cap/Depr 47.06%
Cap/Sales 0.9%
Interest Coverage 3.92
Cash Conversion 58.04%
Profit Quality 95.36%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 3.64
F-Score6
WACC8.95%
ROIC/WACC0.77
Cap/Depr(3y)43.79%
Cap/Depr(5y)50.27%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)77.44%
Profit Quality(5y)102.57%
High Growth Momentum
Growth
EPS 1Y (TTM)10.03%
EPS 3Y5.39%
EPS 5Y3.2%
EPS Q2Q%66.67%
EPS Next Y32.91%
EPS Next 2Y27.03%
EPS Next 3Y23.62%
EPS Next 5Y20.71%
Revenue 1Y (TTM)10%
Revenue growth 3Y10.27%
Revenue growth 5Y8.41%
Sales Q2Q%14.84%
Revenue Next Year12.88%
Revenue Next 2Y11.94%
Revenue Next 3Y10.58%
Revenue Next 5Y8.98%
EBIT growth 1Y77.48%
EBIT growth 3Y2.64%
EBIT growth 5Y0.31%
EBIT Next Year99.93%
EBIT Next 3Y38.05%
EBIT Next 5Y25.59%
FCF growth 1Y-47.17%
FCF growth 3Y-51.81%
FCF growth 5Y-27.98%
OCF growth 1Y-38.28%
OCF growth 3Y-36%
OCF growth 5Y-15.76%